The identification of targets for cancer inhibitors is a complex process that involves understanding the molecular biology of cancer cells. Researchers use techniques such as genomic sequencing, proteomics, and bioinformatics to identify mutated genes or overexpressed proteins that are crucial for tumor growth. Once a target is identified, it undergoes validation to confirm its role in cancer progression.
